Osteoprotegerin and bone loss associated with spaceflight.
Bateman
Ted A
TA
Countryman
S
S
D017209:Apoptosis / Q000502:physiology; D001847:Bone Diseases / Q000139:chemically induced / Q000209:etiology; D001842:Bone and Bones / Q000166:cytology / Q000502:physiology*; D016207:Cytokines / Q000502:physiology; D006023:Glycoproteins / Q000502:physiology* / Q000627:therapeutic use; D006801:Humans; D053244:Osteoprotegerin; D018160:Receptors, Cytoplasmic and Nuclear / Q000502:physiology* / Q000627:therapeutic use; D018124:Receptors, Tumor Necrosis Factor; D013026:Space Flight; D014893:Weightlessness / Q000009:adverse effects*
D016207:Cytokines; D006023:Glycoproteins; D053244:Osteoprotegerin; D018160:Receptors, Cytoplasmic and Nuclear; D018124:Receptors, Tumor Necrosis Factor; C506030:TNFRSF11B protein, human